Which pharma company seeks permission from DGCI for 'phase 2&3' clinic – McqOptions

MCQOPTIONS

1.	Which pharma company seeks permission from DGCI for 'phase 2&3' clinical trials of Oxford vaccine under brand name "Covishield" in India?
A.	Indian Immunologicals
B.	Indian Drugs and Pharmaceuticals Limited
C.	Serum Institute of India
D.	Bharat Biotech
Answer» D. Bharat Biotech

Discussion

No Comment Found

Related MCQs

Which country is hosting the 3rd Edition of Global Exhibition on Services (GES - 2017)?
Prime Minister Narendra Modi on 14 April 2017 dedicated various units of the thermal power plants in Nagpur. Which of the following is not a part of the power plant whose unit was not launched?
India has signed defence deal with which country for advanced Medium-Range Surface-to-Air Missile (MRSAM) systems?
India and the United Kingdom (UK) will set up how much amount (British Pound) of Green Growth Equity Fund (GGEF) to finance clean energy projects?
What is the India's rank in the world's largest tourism economy in terms of GDP, according to the latest report of the World Travel and Tourism Council (WTTC)?
What is the India's rank in the WADA's Anti-Doping Rule Violations (ADRVs) report for year 2015?
What is the India's rank in the 2017 Human Development Index (HDI)?
Which of the following districts will become India's first carbon neutral district?
India has recently signed a Social Security Agreement (SSA) with which country to protect rights of detached workers?
EPFO has extended the last date of submission of digital life certificate through Jeevan Pramaan Patra (JPP) under Employees' Pension Scheme (EPS) till